Teladoc Health, Inc. (TDOC) — Financial statements
Income statement, balance sheet, and cash flow for Teladoc Health, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 2,530↓1.5% | 2,570↓1.3% | 2,602↑8.1% | 2,407↑18.4% | 2,033 | |
| Cost of Revenue | 772↑2.7% | 751↓1.2% | 760↑2.2% | 744↑14.4% | 650 | |
| Gross Profit | 1,758↓3.3% | 1,818↓1.3% | 1,842↑10.8% | 1,663↑20.3% | 1,382 | |
| Operating Expenses | ||||||
| R&D Expenses | 278↓9.6% | 307↓11.8% | 349↑4.5% | 334↑7.0% | 312 | |
| General & Administrative Expenses | 432↓0.8% | 435↓6.3% | 465↑3.3% | 450↑2.7% | 438 | |
| Selling & Marketing Expenses | 653↓28.3% | 911↑0.9% | 903↑6.1% | 851↑27.5% | 667 | |
| SG&A Expenses | 1,085↓19.4% | 1,346↓1.5% | 1,367↑5.1% | 1,301↑17.7% | 1,105 | |
| Other Expenses | 658↓44.5% | 1,186↑216.1% | 375↓97.3% | 13,682↑5825.9% | 231 | |
| Operating Expenses | 2,021↓28.8% | 2,839↑35.8% | 2,091↓86.3% | 15,316↑829.3% | 1,648 | |
| Total Costs & Expenses | 2,793↓22.2% | 3,590↑25.9% | 2,851↓82.2% | 16,060↑598.8% | 2,298 | |
| Operating Results | ||||||
| Operating Income | -263↑74.2% | -1,021↓310.7% | -249↑98.2% | -13,653↓5039.9% | -266 | |
| Depreciation & Amortization | 363↑51.0% | 241↓5.4% | 254↑21.0% | 210↑1.1% | 208 | |
| EBITDA | 147↑364.3% | 32↓27.3% | 44↑678.7% | -8↑76.0% | -31 | |
| EBIT | -216↓3.4% | -209↑0.8% | -211↑3.2% | -217↑9.0% | -239 | |
| Interest & Other Income | ||||||
| Net Interest Income | 17↓48.7% | 33↑35.8% | 25↑364.3% | -9↑88.5% | -80 | |
| Interest Income | 37↓35.6% | 57↑22.0% | 47↑269.1% | 13↑1533.2% | 0.78 | |
| Interest Expense | 20↓17.2% | 24↑6.8% | 22↑1.5% | 22↓73.0% | 81 | |
| Non-Operating Income | -47↑94.2% | -812↓2034.2% | -38↑99.7% | -13,436↓50328.8% | -27 | |
| Other Income / Expenses | 27↑0.7% | 27↓5.9% | 29↑385.8% | -10↑91.5% | -119 | |
| Income Before Tax | -236↑76.3% | -994↓352.5% | -220↑98.4% | -13,663↓3452.1% | -385 | |
| Income Tax Expense | -35↓563.8% | 8↑898.9% | 0.76↑119.9% | -4↓108.6% | 44 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -200↑80.0% | -1,001↓354.4% | -220↑98.4% | -13,660↓3085.6% | -429 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -200↑80.0% | -1,001↓354.4% | -220↑98.4% | -13,660↓3085.6% | -429 | |
| Bottom-Line Net Income | -200↑80.0% | -1,001↓354.4% | -220↑98.4% | -13,660↓3085.6% | -429 | |
| EPS (Basic) | -1.14↑80.6% | -5.87↓331.6% | -1.36↑98.4% | -84.60↓2998.9% | -2.73 | |
| EPS (Diluted) | -1.14↑80.6% | -5.87↓338.1% | -1.34↑98.4% | -84.60↓2998.9% | -2.73 | |
| Weighted Average Shares | 176↑3.3% | 171↑5.2% | 162↑0.4% | 161↑2.9% | 157 | |
| Weighted Average Diluted Shares | 176↑3.3% | 171↑3.6% | 165↑1.9% | 161↑2.9% | 157 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.